Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis

Area of Science:

• Gastroenterology
• Metabolic Biochemistry

Background:

• Hydrogen sulfide (HS-) is implicated in ulcerative colitis (UC) pathogenesis.
• HS- is known to inhibit butyrate oxidation in colonocytes.
• Excess fecal HS- is observed in UC patients.

Purpose of the Study:

• To investigate the pathogenic role of free and bound fecal HS- in UC.
• To determine the metabolic effect of HS- on butyrate oxidation in rat colonocytes.
• To compare fecal HS- levels and binding capacity in health and UC.

Main Methods:

• Isolated rat colonocytes were incubated with butyrate.
• Addition of HS- in water, fecal filtrates with HS-, and HS- bound by fecal agents.
• Carbon dioxide (CO2) production quantified to assess butyrate oxidation rates.
• Fecal total and free HS-, and HS- binding capacity measured.

Main Results:

• HS- significantly reduced CO2 production in a dose-dependent manner.
• Fecal filtrates containing HS- showed a reduced inhibitory effect compared to free HS-.
• Fecal HS- levels and binding capacity did not differ between healthy individuals and UC patients.
• Bound HS- had minimal impact on CO2 production.
• Non-HS- related fecal agents reduced butyrate oxidation by approximately 25%.

Conclusions:

• Fecal HS- has a limited effect on colonocyte butyrate oxidation.
• HS- is unlikely to be a primary pathogenic factor in UC via metabolic impairment.
• Other unidentified fecal agents may be more significant inhibitors of colonic metabolism in UC.
• The role of colonic contents in UC pathogenesis requires further investigation.